Monophasic Acquired Demyelinating Syndromes of the Central Nervous System in Children

Banwell, 2009, Incidence of acquired demyelination of the CNS in Canadian children, Neurology, 72, 232, 10.1212/01.wnl.0000339482.84392.bd Absoud, 2013, Paediatric acquired demyelinating syndromes: Incidence, clinical and magnetic resonance imaging features, Mult Scler J, 19, 76, 10.1177/1352458512445944 Hacohen, 2015, Myelin oligodendrocyte glycoprotein antibodies are associated with a non-MS course in children, Neurol Neuroimmunol Neuroinflamm, 2, e81, 10.1212/NXI.0000000000000081 Waters, 2020, Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes, JAMA Neurol, 77, 82, 10.1001/jamaneurol.2019.2940 Banwell, 2011, Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: A prospective national cohort study, Lancet Neurol, 10, 436, 10.1016/S1474-4422(11)70045-X Hacohen, 2014, Autoantibody biomarkers in childhood-acquired demyelinating syndromes: Results from a national surveillance cohort, J Neurol Neurosurg Psychiatry, 85, 456, 10.1136/jnnp-2013-306411 Waldman, 2011, Management of pediatric central nervous system demyelinating disorders: Consensus of United States neurologists, J Child Neurol, 26, 675, 10.1177/0883073810395141 Brenton, 2022, Pediatric acquired demyelinating disorders, Contin Lifelong Learn Neurol, 28, 1104, 10.1212/CON.0000000000001128 Brenton, 2016, Therapeutic approach to the management of pediatric demyelinating disease: Multiple sclerosis and acute disseminated encephalomyelitis, Neurotherapeutics, 13, 84, 10.1007/s13311-015-0396-0 Sloka, 2005, The mechanism of action of methylprednisolone in the treatment of multiple sclerosis, Mult Scler J, 11, 425, 10.1191/1352458505ms1190oa Brusaferri, 2000, Steriods for multiple sclerosis and optic neuritis: a meta-analysis of randomized controlled clinical trials, J Neurol, 247, 435, 10.1007/s004150070172 Chitnis, 2012, Consensus statement: Evaluation of new and existing therapeutics for pediatric multiple sclerosis, Mult Scler J, 18, 116, 10.1177/1352458511430704 Lünemann, 2016, Efficacy of intravenous immunoglobulin in neurological diseases, Neurotherapeutics, 13, 34, 10.1007/s13311-015-0391-5 Sorensen, 2003, The role of intravenous immunoglobulin in the treatment of multiple sclerosis, J Neurol Sci, 206, 123, 10.1016/S0022-510X(02)00343-X Bigi, 2015, Outcomes after early administration of plasma exchange in pediatric central nervous system inflammatory demyelination, J Child Neurol, 30, 874, 10.1177/0883073814545883 Weinshenker, 1999, A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease, Ann Neurol, 46, 878, 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q Rodriguez, 1993, Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination, Neurology, 43, 1100, 10.1212/WNL.43.6.1100 Magaña, 2011, Beneficial plasma exchange response in central nervous system inflammatory demyelination, Arch Neurol, 68, 870, 10.1001/archneurol.2011.34 Keegan, 2002, Plasma exchange for severe attacks of CNS demyelination: Predictors of response, Neurology, 58, 143, 10.1212/WNL.58.1.143 Llufriu, 2009, Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months, Neurology, 73, 949, 10.1212/WNL.0b013e3181b879be Eyre, 2018, Therapeutic plasma exchange in paediatric neurology: A critical review and proposed treatment algorithm, Dev Med Child Neurol, 60, 765, 10.1111/dmcn.13925 Krupp, 2013, International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions, Mult Scler J, 19, 1261, 10.1177/1352458513484547 Santoro, 2019, Diagnostic considerations in acute disseminated encephalomyelitis and the interface with MOG antibody, Neuropediatrics, 50, 273, 10.1055/s-0039-1693152 Tenembaum, 2007, Acute disseminated encephalomyelitis, Neurology, 68, S23, 10.1212/01.wnl.0000259404.51352.7f Dale, 2000, Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children, Brain, 123, 2407, 10.1093/brain/123.12.2407 Pohl, 2008, Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions, Curr Opin Neurol, 21, 366, 10.1097/WCO.0b013e3282fd172b Pohl, 2016, Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome, Neurology, 87, S38, 10.1212/WNL.0000000000002825 Pohl, 2012, Treatment of acute disseminated encephalomyelitis, Curr Treat Options Neurol, 14, 264, 10.1007/s11940-012-0170-0 Kahn, 2020, Acute transverse myelitis and acute disseminated encephalomyelitis, Pediatr Rev, 41, 313, 10.1542/pir.2019-0179 Cole, 2019, Acute disseminated encephalomyelitis in children: An updated review based on current diagnostic criteria, Pediatr Neurol, 100, 26, 10.1016/j.pediatrneurol.2019.06.017 Nishikawa, 1999, Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis, Pediatr Neurol, 21, 583, 10.1016/S0887-8994(99)00042-9 Pradhan, 1999, Intravenous immunoglobulin therapy in acute disseminated encephalomyelitis, J Neurol Sci, 165, 56, 10.1016/S0022-510X(99)00072-6 Dale, 2009, Pediatric central nervous system inflammatory demyelination: Acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis, Curr Opin Neurol, 22, 233, 10.1097/WCO.0b013e32832b4c47 Banwell, 2023, Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria, Lancet Neurol, 22, 268, 10.1016/S1474-4422(22)00431-8 Absoud, 2011, Severe acute disseminated encephalomyelitis: A paediatric intensive care population-based study, Mult Scler J, 17, 1258, 10.1177/1352458510382554 Shilo, 2016, Long-term motor, cognitive and behavioral outcome of acute disseminated encephalomyelitis, Eur J Paediatr Neurol, 20, 361, 10.1016/j.ejpn.2016.01.008 Iype, 2018, Factors related to long term motor, behavioral, and scholastic outcome in children with acute disseminated encephalomyelitis, Pediatr Neurol, 89, 49, 10.1016/j.pediatrneurol.2018.08.015 Lock, 2019, Update on pediatric optic neuritis, Curr Opin Ophthalmol, 30, 418, 10.1097/ICU.0000000000000607 Chang, 2017, Pediatric optic neuritis, Semin Pediatr Neurol, 24, 122, 10.1016/j.spen.2017.04.004 Wu, 2015, Optic neuritis: A model for the immuno-pathogenesis of central nervous system inflammatory demyelinating diseases, Curr Immunol Rev, 11, 85, 10.2174/1573395511666150707181644 Pau, 2011, Optic neuritis, Eye Lond Engl, 25, 833 Wan, 2014, Visual outcomes in pediatric optic neuritis, Am J Ophthalmol, 158, 503, 10.1016/j.ajo.2014.05.036 2011, Optic neuritis in children, 223 Pineles, 2020, Assessment of pediatric optic neuritis visual acuity outcomes at 6 months, JAMA Ophthalmol, 138, 1253, 10.1001/jamaophthalmol.2020.4231 Heussinger, 2015, Oligoclonal bands predict multiple sclerosis in children with optic neuritis: OCB in children with ON, Ann Neurol, 77, 1076, 10.1002/ana.24409 Waldman, 2011, Pediatric optic neuritis and risk of multiple sclerosis: Meta-analysis of observational studies, J Am Assoc Pediatr Ophthalmol Strabismus, 15, 441, 10.1016/j.jaapos.2011.05.020 Borchert, 2017, Pediatric optic neuritis: What is new, J Neuroophthalmol, 37, S14, 10.1097/WNO.0000000000000551 Beck, 1992, A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis, N Engl J Med, 326, 581, 10.1056/NEJM199202273260901 Blackburn, 2020, Revisiting transverse myelitis: Moving toward a new nomenclature, Front Neurol, 11, 10.3389/fneur.2020.519468 Absoud, 2016, Pediatric transverse myelitis, Neurology, 87, S46, 10.1212/WNL.0000000000002820 Wolf, 2012, Pediatric acute transverse myelitis overview and differential diagnosis, J Child Neurol, 27, 1426, 10.1177/0883073812452916 Wang, 2019, Clinical approach to pediatric transverse myelitis, neuromyelitis optica spectrum disorder and acute flaccid myelitis, Children, 6, 70, 10.3390/children6050070 Hardy, 2020, Update on acute flaccid myelitis: recognition, reporting, aetiology and outcomes, Arch Dis Child, 105, 842, 10.1136/archdischild-2019-316817 Pidcock, 2007, Acute transverse myelitis in childhood: Center-based analysis of 47 cases, Neurology, 68, 1474, 10.1212/01.wnl.0000260609.11357.6f 2002, Proposed diagnostic criteria and nosology of acute transverse myelitis, Neurology, 59, 499, 10.1212/WNL.59.4.499 2011, Acute complete transverse myelitis in children, 243 Yiu, 2009, Acute transverse myelitis and acute disseminated encephalomyelitis in childhood: Spectrum or separate entities?, J Child Neurol, 24, 287, 10.1177/0883073808323522 Defresne, 2001, Efficacy of high dose steroid therapy in children with severe acute transverse myelitis, J Neurol Neurosurg Psychiatry, 71, 272, 10.1136/jnnp.71.2.272 Noland, 2018, Safety and efficacy of plasma exchange in pediatric transverse myelitis, Neurol Clin Pract, 8, 327, 10.1212/CPJ.0000000000000480 Helfferich, 2021, Prognostic factors for relapse and outcome in pediatric acute transverse myelitis, Brain Dev, 43, 626, 10.1016/j.braindev.2020.12.019 Chitnis, 2016, Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report, Neurology, 86, 245, 10.1212/WNL.0000000000002283 Gombolay, 2018, Pediatric neuromyelitis optica spectrum disorders, Curr Treat Options Neurol, 20, 19, 10.1007/s11940-018-0502-9